GETZ PHARMA
Getz Pharma is a member of the Getz Group of Companies, which has a legacy of over 160 years. The Getz Group was founded in 1852 by a Prussian immigrant Joseph Getz and his three brothers in Lower Lake, California, and began as a local general store. By the 1870s, the Getz Brothers were marketing medicines, food products, and consumer goods to customers in Shanghai, Hong Kong, Calcutta and Madras. Today, the Getz Group is home to more than 12,000 employees worldwide and distributes agricultural, biomedical, pharmaceutical and technical products and consumer goods in over 50 countries across the world. Getz Pharma was initially set up in 1995 by Getz Brothers & Co. Inc. At inception and formation in 1995, Getz Pharma employed 45 people, and had a small revenue base with no international operations. Today, Getz Pharma has transformed from a small manufacturing facility to a world-class branded generic pharmaceutical company with a global outlook. It employs more than 5,700 highly qualified people worldwide and has operations in South Asia, Central Asia, South-East Asia, Asia-Pacific, the Middle East and Africa.
NOVUGEN PHARMA
Novugen is a wholly owned subsidiary of SciTech International, a UAE-based group with over 30 years of experience in the pharmaceutical industry. The company specializes in developing world-class manufacturing facilities and providing fully integrated finished pharmaceutical products globally, supported by its advanced R&D and manufacturing network.
Novugen Pharma Uzbekistan, acquired in 2019, was revamped to meet the latest CGMP standards, enabling entry into the Commonwealth of Independent States (CIS) and Eurasian markets. This strategic expansion strengthens our presence in these growing regions. Since becoming fully operational, our Uzbekistan facility has launched over 25 products developed at our global R&D center in Malaysia, expanding our portfolio across major therapeutic areas.
